Straumann Holding AG Cash Flow from Financial Activities 2012-2025 | SAUHY
Straumann Holding AG annual/quarterly cash flow from financial activities history and growth rate from 2012 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- Straumann Holding AG cash flow from financial activities for the quarter ending December 31, 2025 was $-0.128B, a 20.91% decline year-over-year.
- Straumann Holding AG cash flow from financial activities for the twelve months ending December 31, 2025 was $-0.970B, a 267.19% increase year-over-year.
- Straumann Holding AG annual cash flow from financial activities for 2025 was $-0.128B, a 33.41% decline from 2024.
- Straumann Holding AG annual cash flow from financial activities for 2024 was $-0.192B, a 59.38% decline from 2023.
- Straumann Holding AG annual cash flow from financial activities for 2023 was $-0.473B, a 192.35% increase from 2022.
|
Straumann Holding AG Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2025 | $-128 |
| 2024 | $-192 |
| 2023 | $-473 |
| 2022 | $-162 |
| 2021 | $-144 |
| 2020 | $164 |
| 2019 | $-158 |
| 2018 | $-79 |
| 2017 | $196 |
| 2016 | $-261 |
| 2015 | $-286 |
| 2014 | $-49 |
| 2013 | $-168 |
| 2012 | $-68 |
| 2011 | $-102 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $16.902B | $3.144B |
| The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |